Skip to main content
Top
Published in: European Radiology 11/2017

Open Access 01-11-2017 | Cardiac

Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis

Authors: Simon Greulich, Agnes Mayr, Daniel Kitterer, Joerg Latus, Joerg Henes, Francesco Vecchio, Philipp Kaesemann, Alexandru Patrascu, Andreas Greiser, Stefan Groeninger, Francesco Romeo, Niko Braun, M. Dominik Alscher, Udo Sechtem, Heiko Mahrholdt

Published in: European Radiology | Issue 11/2017

Login to get access

Abstract

Objectives

Rheumatoid arthritis (RA) patients are at increased risk of suffering from adverse cardiovascular events. Cardiovascular magnetic resonance (CMR) mapping techniques might be appropriate tools to complement late gadolinium enhancement (LGE) for the assessment of myocardial involvement. This study aimed to perform advanced myocardial tissue characterisation in RA patients by a multicomponent CMR protocol.

Methods

22 RA patients were prospectively enrolled and underwent CMR, including LGE and T1/T2 mapping sequences; 20 volunteers served as controls.

Results

Mean LV-EF was 66%; prevalence of LGE was 18%. RA patients had increased native T1 (985 vs. 959 ms, p = 0.03), expanded extracellular volume (ECV) (27 vs. 25%, p = 0.02) and higher T2 values (52 vs. 49 ms, p < 0.001) compared to controls irrespective of the presence of LGE. T2 mapping showed the highest prevalence of values beyond the 95% percentile of controls.

Conclusion

RA patients demonstrated higher T1, ECV and T2 values compared to controls, with most significant differences for T2. Since these results seem to be independent of the presence of LGE, advanced myocardial tissue characterisation including CMR mapping techniques in addition to LGE-CMR might be useful in the evaluation of myocardial involvement in RA patients.

Key points

RA patients had higher T1, ECV and T2 values compared to controls.
Most significant differences were observed for T2.
Our results seem to be independent of the presence of LGE.
Mapping might be useful in the evaluation of myocardial involvement in RA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799CrossRef Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799CrossRef
2.
go back to reference Maradit-Kremers H, Crowson CS, Nicola PJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411CrossRef Maradit-Kremers H, Crowson CS, Nicola PJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411CrossRef
3.
go back to reference Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36–40PubMed Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36–40PubMed
4.
go back to reference Roman MJ, Salmon JE (2007) Cardiovascular manifestations of rheumatologic diseases. Circulation 116:2346–2355CrossRef Roman MJ, Salmon JE (2007) Cardiovascular manifestations of rheumatologic diseases. Circulation 116:2346–2355CrossRef
5.
go back to reference Gerster M, Peker E, Nagel E, Puntmann VO (2016) Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care. Expert Rev Cardiovasc Ther 6:1–13 Gerster M, Peker E, Nagel E, Puntmann VO (2016) Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care. Expert Rev Cardiovasc Ther 6:1–13
6.
go back to reference Nicola PJ, Crowson CS, Maradit-Kremers H et al (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60–67CrossRef Nicola PJ, Crowson CS, Maradit-Kremers H et al (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60–67CrossRef
7.
go back to reference Giles JT, Fernandes V, Lima JA, Bathon JM (2005) Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7:195–207CrossRef Giles JT, Fernandes V, Lima JA, Bathon JM (2005) Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7:195–207CrossRef
8.
go back to reference Prasad M, Hermann J, Gabriel SE et al (2015) Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol 12:168–176CrossRef Prasad M, Hermann J, Gabriel SE et al (2015) Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol 12:168–176CrossRef
9.
go back to reference Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2008) The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 58:2603–2611CrossRef Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2008) The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 58:2603–2611CrossRef
10.
go back to reference Radunski UK, Lund GK, Stehning C et al (2014) CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 7:667–675CrossRef Radunski UK, Lund GK, Stehning C et al (2014) CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 7:667–675CrossRef
11.
go back to reference Lurz P, Luecke C, Eitel I et al (2016) Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial. J Am Coll Cardiol 67:1800–1811CrossRef Lurz P, Luecke C, Eitel I et al (2016) Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial. J Am Coll Cardiol 67:1800–1811CrossRef
12.
go back to reference Puntmann VO, Carr-White G, Jabbour A et al (2016) International T1 multicentre CMR outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRef Puntmann VO, Carr-White G, Jabbour A et al (2016) International T1 multicentre CMR outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRef
13.
go back to reference Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15:91 Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15:91
14.
go back to reference Schultz A, Caspar T, Schaeffer M et al (2016) Late gadolinium enhancement cardiac imaging on a 3T scanner with parallel RF transmission technique: prospective comparison of 3D-PSIR and 3D-IR. Eur Radiol 26:1547–1555CrossRef Schultz A, Caspar T, Schaeffer M et al (2016) Late gadolinium enhancement cardiac imaging on a 3T scanner with parallel RF transmission technique: prospective comparison of 3D-PSIR and 3D-IR. Eur Radiol 26:1547–1555CrossRef
15.
go back to reference Moon JC, Messroghli DR, Kellman P et al (2013) Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92CrossRef Moon JC, Messroghli DR, Kellman P et al (2013) Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92CrossRef
16.
go back to reference Giri S, Chung YC, Merchant A et al (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56CrossRef Giri S, Chung YC, Merchant A et al (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56CrossRef
17.
go back to reference Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRef Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRef
18.
go back to reference Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRef Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRef
19.
go back to reference Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708CrossRef Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708CrossRef
20.
go back to reference He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN (2008) Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 60:1082–1089CrossRef He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN (2008) Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 60:1082–1089CrossRef
21.
go back to reference Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRef Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRef
22.
go back to reference Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRef Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRef
23.
go back to reference Kobayashi Y, Giles JT, Hirano M et al (2010) Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 12:R171CrossRef Kobayashi Y, Giles JT, Hirano M et al (2010) Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 12:R171CrossRef
24.
go back to reference Ntusi NA, Piechnik SK, Francis JM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526–536CrossRef Ntusi NA, Piechnik SK, Francis JM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526–536CrossRef
25.
go back to reference Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD (2014) Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging 29:147–154CrossRef Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD (2014) Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging 29:147–154CrossRef
26.
go back to reference Greulich S, Arai AE, Sechtem U, Mahrholdt H (2016) Recent advances in cardiac magnetic resonance. F1000Res. doi:10.12688/f1000research.8383.1CrossRef Greulich S, Arai AE, Sechtem U, Mahrholdt H (2016) Recent advances in cardiac magnetic resonance. F1000Res. doi:10.12688/f1000research.8383.1CrossRef
28.
go back to reference Hinojar R, Varma N, Child N et al (2015) T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.115.003285 CrossRef Hinojar R, Varma N, Child N et al (2015) T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. doi:10.​1161/​CIRCIMAGING.​115.​003285 CrossRef
29.
go back to reference Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903CrossRef Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903CrossRef
30.
go back to reference Holmström M, Koivuniemi R, Korpi K et al (2016) Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 34:416–423PubMed Holmström M, Koivuniemi R, Korpi K et al (2016) Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 34:416–423PubMed
Metadata
Title
Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis
Authors
Simon Greulich
Agnes Mayr
Daniel Kitterer
Joerg Latus
Joerg Henes
Francesco Vecchio
Philipp Kaesemann
Alexandru Patrascu
Andreas Greiser
Stefan Groeninger
Francesco Romeo
Niko Braun
M. Dominik Alscher
Udo Sechtem
Heiko Mahrholdt
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-4838-4

Other articles of this Issue 11/2017

European Radiology 11/2017 Go to the issue